Determination of Insulin-Like Growth Factor-I in the Monitoring of Growth Hormone Treatment with Respect to Efficacy of Treatment and Side Effects: Should Potential Risks of Cardiovascular Disease and Cancer Be Considered?

Publisher： Karger

E-ISSN： 1663-2826|51|3|141-148

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.51, Iss.3, 2004-11, pp. : 141-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency

By  

Hormone Research in Paediatrics, Vol. 86, Iss. 6, 2016-11 ,pp. : 361-397

Karger

Access to resources Recommend Favorite

Principles of Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children with Idiopathic Short Stature

By  

Hormone Research in Paediatrics, Vol. 76, Iss. 3, 2011-09 ,pp. : 24-26

Karger

Access to resources Recommend Favorite

Reflections on the US Guidelines on Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents

By  

Hormone Research in Paediatrics, Vol. 86, Iss. 6, 2016-11 ,pp. : 398-402

Karger

Access to resources Recommend Favorite

To Prime or Not to Prime – Is That Still a Question? A Comment on the US Guidelines on Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents

By  

Hormone Research in Paediatrics, Vol. 88, Iss. 2, 2017-05 ,pp. : 179-180

Karger

Access to resources Recommend Favorite

Genetic Disorders in the Growth Hormone – Insulin-Like Growth Factor-I Axis

By  

Hormone Research in Paediatrics, Vol. 66, Iss. 5, 2006-10 ,pp. : 221-230

Karger

Access to resources Recommend Favorite